Ebit Alterar Data
Alaunos Therapeutics USD -952K 60K 2026-06
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Baxter International USD 314M 38M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bioline Rx USD -4.13M 1.79M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Celltrion KRW 20.08B 6.67B 2026-06
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Curis USD -11.52M 3.64M 2026-03
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Divis Laboratories Ltd INR 14.24B 2.95B 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
J&J USD 6.47B 1B 2026-09
Kangmei Pharma CNY -35.26M 22.54M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Merck USD 7.33B 6.49B 2026-09
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Novartis USD 5.14B 411M 2026-09
Organigram Holdings CAD 5.33M 15.12M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pfizer USD 4.85B 5.03B 2026-09
Pharma Mar EUR 7.65M 9.06M 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Qiagen NV USD 141.4M 44.52M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
TG Therapeutics USD 85.9M 64.22M 2026-09
Tilray USD -20.01M 9.34M 2025-09
Verastem USD -44.9M 3.42M 2026-03
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 222.81M 140.02M 2026-09